Home Monitoring in Massachusetts

Zoomax Technology manufactures electronic vision aids and digital magnification devices designed for low vision and age-related macular degeneration. The company produces portable digital magnifiers, handheld magnifiers, electronic glasses, and desktop magnification systems. Primary products include the Snow Pad (portable digital magnifier with iPad integration), Snow 12 (12-inch screen portable magnifier), Luna 6 (handheld magnifier), and Acesight VR (wearable electronic glasses for television viewing). These devices are marketed toward individuals with vision loss, ophthalmology practices, educators, and institutions serving visually impaired populations. Zoomax devices enable reading, writing, educational engagement, and television viewing by providing magnified digital displays. The company offers a 30-day free trial and 2-year warranty on products. Distribution appears to be direct-to-consumer and through healthcare providers and educational institutions. No specific FDA, ISO, or CE certifications are mentioned on the fetched homepage.

InfoBionic, Inc. is a virtual cardiac telemetry company specializing in AI-enabled remote cardiac monitoring. The company's flagship product, MoMe ARC® (Advanced Remote Cardiology), is recognized as the gold standard in remote cardiac ECG monitoring and represents the first platform to market with hospital-grade continuous monitoring capability deployable from nearly any location. The MoMe ARC® platform integrates advanced artificial intelligence to enhance clinical workflow, detect previously undetected cardiac anomalies, and enable rapid interventions at scale. InfoBionic offers a comprehensive suite comprising MoMe Solutions (AI-enabled ECG analysis), MoMe Sensors (interchangeable, tiered biosensor lead sets configurable for varying acuity levels from high-acuity diagnostics to portable monitoring), and MoMe Analytics™ (business intelligence and AI-embedded analytics for cardiac care operations). The company targets cardiology practices, cardiologists, electrophysiologists, medical leaders, hospital systems, and virtual health programs. InfoBionic has received FDA clearance for its MoMe ARC® Patch (announced August 2025), affirming regulatory compliance and clinical safety. The platform transforms cardiac data into actionable clinical insight through proprietary AI algorithms focused on arrhythmia detection, atrial fibrillation monitoring, and congenital heart disease assessment. Products are designed to improve patient quality of life through earlier interventions, enhance operational efficiency across departments, and support both enterprise and telehealth deployment models.

LympheDIVAs is a USA-based medical compression garment manufacturer specializing in stylish, medically-graded lymphedema compression apparel. Operating from Dalton, Massachusetts, the company produces a comprehensive line of compression arm sleeves, gauntlets, gloves, and support socks in graduated compression levels (15-40mmHg). All products feature seamless construction with 360-degree stretch, moisture-wicking nylon-Lycra blend fabrics, and latex/silicone-free gripper bands. The garments are designed for lymphedema management, post-surgical recovery, and general lymphatic support while maintaining fashion-forward aesthetics. LympheDIVAs manufactures entirely in the USA and markets directly to consumers (D2C) through their online storefront, emphasizing clinical efficacy combined with contemporary design for patients seeking therapeutic compression without medical stigma.

LeviSense Medical develops an advanced instrumented bed system designed to prevent and treat pressure injuries (pressure ulcers/bed sores) through high-resolution sensing and automated surface control. The LeviSense Pro-Daptive™ SensorCell™ Flotation Surface continuously scans patient form, position, and movement multiple times per second, automatically adjusting the support surface to redistribute pressure and protect vulnerable areas without requiring caregiver intervention. The system features 16 programmable sections for patient-specific customization, Dynamic Offloading™ for automated pressure relief, and Heel Flotation™ for targeted protection. Key benefits include reduced nursing labor demands, decreased repositioning-related injury risk to patients and caregivers, and enhanced patient comfort through advanced envelopment technology. Compatible with standard hospital and home bed frames, the system integrates remote monitoring capabilities and is designed for seamless deployment across ICU through home-care settings, supporting institutional and home-based care delivery models.

Empatica is a digital health company specializing in FDA-cleared wearable devices and clinical-grade digital biomarker platforms for remote patient monitoring and clinical research. The company develops continuous health monitoring solutions that collect physiological data from everyday life, with particular expertise in neurological applications including epilepsy monitoring and Parkinson's disease assessment. Empatica's Health Monitoring Platform is an end-to-end remote monitoring solution designed for clinical trials, providing raw data collection and validated digital biomarkers across multiple therapeutic areas. The platform features over 300 digital measures derived from wearable sensors, supporting objective monitoring of motor symptoms, seizure detection, and treatment response. Empatica holds 8 FDA clearances and CE MDR certification. The company's wearable devices, including the EmbraceMini and EpiMonitor, are deployed across 160+ countries in over 40 languages. More than half of the top 20 pharmaceutical companies use the Empatica platform for clinical trial monitoring and digital endpoint development. The technology has been referenced in over 12,000 research publications. Empatica serves pharmaceutical companies, contract research organizations, academic medical centers, and healthcare systems requiring objective, continuous health data collection outside traditional clinical settings.

Podimetrics, Inc. develops remote monitoring solutions for diabetic foot health and complex diabetes care management. The company manufactures the SmartMat™ (and next-generation SmartMat+), an FDA-cleared wearable platform that detects early signs of foot inflammation and diabetic foot ulcers through daily 20-second contact monitoring. The SmartMat collects thermal and pressure data to identify high-risk individuals before complications emerge. The solution integrates remote monitoring technology with personalized clinical support and timely alerts to enable early intervention. Podimetrics targets payors, healthcare systems, and employers managing high-risk diabetic populations. Clinical evidence supports reductions in amputations, hospitalizations, and diabetes-related complications. The company emphasizes that 85% of diabetic foot ulcers are preventable, and one-third of diabetes spending addresses lower-extremity complications. The platform combines hardware, cloud-based analytics, and clinical outreach services to support complex diabetes care workflows and improve outcomes while reducing utilization costs.

WatchRx is a digital healthcare platform built around smartwatch-enabled remote patient monitoring (RPM), chronic care management (CCM), transitional care management (TCM), and medication adherence solutions. The company provides an AI/ML-enabled cloud platform that integrates wearable technology to collect real-time patient vital signs and behavioral data, enabling clinicians to deliver proactive, value-based care and improve patient outcomes while reducing hospitalizations and urgent care visits. Primary markets include independent practices and primary care clinics, hospital systems, accountable care organizations (ACOs), and senior living and home care facilities. The platform automates clinical workflows, generates actionable insights for physicians, and supports medication adherence monitoring and GPS tracking for senior populations. Clinical evidence cited on the site demonstrates 76% reduction in hospitalizations, 51% reduction in urgent visits, and 90% patient satisfaction. The solution generates approximately $220+ additional revenue per patient per month through RPM/CCM billing codes. WatchRx partners with major healthcare networks and UnitedHealth Group. The company serves the growing market of value-based care delivery and remote monitoring, targeting reduction of healthcare costs and physician burnout while improving care coordination and patient engagement.

BioSensics is a wearable sensor and digital health technology company founded in 2007 by three Harvard University scientists. The company specializes in developing FDA-registered medical devices and digital biomarkers for clinical trials, remote patient monitoring, and health assessments, particularly for older adults and neurological disorders. BioSensics' core offerings include advanced fall detection and prevention systems with automatic fall alert capabilities, continuous monitoring of fall risk and physical activity, balance and gait assessment technologies, and cognitive function monitoring sensors. The company also provides the BioDigit Home platform, a centralized data aggregation system that integrates data from various digital health technologies. BioSensics has licensed its fall detection technology to major retailers and medical device manufacturers and provides comprehensive operational and technical services for clinical research across therapeutic areas including Alzheimer's disease, Parkinson's disease, and stroke. With over $50 million in NIH funding support, BioSensics has established itself as a leader in objective measurement of disease symptoms and validated biomarkers for clinical and research applications.

Firefly Global is a leading manufacturer of wireless portable digital magnifying cameras and video transmission systems for medical and veterinary professionals. The company specializes in high-definition digital imaging devices including wireless video otoscopes for ENT and audiology, endoscope camera systems with universal couplers for EMR integration, digital dermatoscopes with advanced polarizing optics, and telemedicine peripherals compatible with iPhone, iPad, Android, Windows, and Mac OS. Firefly's product portfolio also includes scientific and industrial digital microscopes with magnification up to 230x, veterinary examination tools, and precision accessories such as specula dispensers and TV adapters. Serving hospitals, clinics, medical schools, and veterinary practices across North America, Europe, and Asia, Firefly devices enable clinicians and specialists to capture, document, and stream high-quality live video for improved patient evaluation, education, and remote healthcare delivery.

AION Biosystems develops and commercializes the AION TempShield™, an FDA-cleared Class II medical device for continuous, non-invasive body temperature monitoring. The TempShield is a wearable sensor designed for 24/7 real-time tracking with up to 90 days of battery life per charge. The device features Bluetooth connectivity, mobile app integration, and seamless electronic medical record (EMR) integration, supported by a dedicated clinician dashboard. Reimbursable under CMS code 99454, the TempShield targets early detection of infection-related complications across multiple clinical settings: oncology (60% of cancer deaths are infection-related), post-operative care (23.7% of surgical patients experience postoperative fever), pediatrics (75,000 children develop sepsis annually in the U.S.), long-term care facilities, and general sepsis management. The device addresses a critical care gap by enabling earlier identification of infection before progression to severe sepsis or organ failure, potentially reducing hospitalizations, readmissions, and associated healthcare costs. Clinical evidence cited on the company website demonstrates that each hour of delay in antibiotic administration for sepsis increases mortality risk by 7.6%, making early detection instrumental to patient outcomes. Manufacturing and regulatory capabilities include FDA 510(k) clearance and integration with major health information systems.

Whoop, Inc. manufactures WHOOP, a 24/7 wearable health monitoring device designed for personal wellness, fitness optimization, and recovery tracking. The device combines continuous heart rate monitoring, sleep analysis, strain/recovery quantification, and stress monitoring via screen-free wrist-worn sensors that collect data every second. WHOOP offers three tiered membership levels (One, Peak, Life) with increasingly advanced features including VO2 Max tracking, heart rate zones, women's hormonal cycle insights, blood pressure monitoring (beta), ECG readings, and atrial fibrillation detection. The platform emphasizes personalized coaching and behavioral insights tied to sleep duration, physical activity, and recovery metrics. Advanced Labs is an ancillary service offering 65+ biomarker analysis integrated with 24/7 wearable data. The WHOOP 5.0 and WHOOP MG devices feature 14+ day battery life, waterproof design, and customizable wear options (leather, sport, flex, apparel). Target market spans consumer fitness enthusiasts, athletes, and wellness-focused individuals. Membership is HSA/FSA eligible. ECG and blood pressure features carry age and medical contraindications; advanced monitoring features are medically regulated and region-restricted. The company emphasizes data privacy and clinician-reviewed results.

Boston Easy Biotech Inc manufactures and distributes rapid diagnostic testing solutions under the Famwell™ brand. The company focuses on point-of-care and over-the-counter (OTC) rapid testing products designed for both clinical laboratory and at-home consumer use. Product lines include respiratory testing, fertility testing, and drug-of-abuse testing. The company targets clinical laboratories, pharmacy chains, retail channels, and consumers seeking fast, reliable diagnostic results. Boston Easy Biotech exhibits at major industry conferences including ADLM 2026 (American Association for Clinical Laboratory Science) and NACDS Total Store Expo 2026, positioning itself within the evolving diagnostics landscape and OTC consumer health segments. All products emphasize ease of use and reliability. The company is based in Andover, Massachusetts, and operates customer order fulfillment and support services.

Predictive Healthcare, Inc. develops MyHealthPal™, an FDA-listed Class I medical device platform for remote postoperative surgical site infection (SSI) monitoring. The platform uses artificial intelligence and standard consumer smart devices (smartphones) to enable patients to submit wound photos and clinical inputs that feed into an algorithm assessing SSI risk in real time. Clinicians receive predictive risk alerts to guide postoperative decision-making and early intervention. The system integrates with existing electronic medical record (EMR) systems and supports asynchronous postoperative visits, reducing unnecessary in-person wound checks while maintaining vigilant monitoring for patients with geographic or social barriers to care access. MyHealthPal addresses a significant clinical need: approximately 5 in 100 surgeries result in SSI, costing US hospitals $10 billion annually. The company is FDA-registered and operates under a Class I medical device designation. The platform is currently available for sale in the United States only and is positioned for perioperative programs across surgical specialties, with demonstrated interest in orthopedic, spinal, pediatric, and general surgery applications.

MedMinder is a comprehensive digital healthcare platform specializing in medication adherence and connected care solutions for elderly patients, individuals with chronic illnesses, and those with cognitive or developmental impairments. Founded in 2007 and headquartered in Norwood, Massachusetts, the company provides an integrated ecosystem combining smart hardware, cloud-based software, pharmacy services, and remote monitoring capabilities. The MedMinder smart pill dispenser automates medication organization and delivery while generating actionable digital insights. The platform includes a user-friendly mobile app, secure cloud infrastructure, full-service digital pharmacy with prescription synchronization, and personalized data analytics. MedMinder serves providers, payors, and caregivers, enabling real-time medication tracking, remote monitoring, caregiver notifications, and improved communication between patients and clinical teams. The solution reduces medication errors, enhances medication compliance, supports independent living, and streamlines provider workflows while driving value-based care outcomes.

Implicity is a cloud-based digital MedTech software company specializing in AI-driven remote cardiac monitoring and research solutions for healthcare providers. Founded in 2016, the platform centralizes and standardizes cardiac implantable electronic device (CIED) data from multiple manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic, Microport) into a single unified dashboard. The FDA-cleared, CE-marked platform employs patented AI algorithms to filter clinical alerts, reduce false positives by up to 79%, and prioritize clinically relevant events for faster clinical decision-making. Key solutions include vendor-neutral CIED remote monitoring, ILR ECG Analyzer (for Medtronic implantable loop recorders), AF Alert Management, SignalHF Predictive AI for heart failure risk stratification, and advanced research tools for real-time clinical data collection. The platform demonstrates proven clinical impact: 26% reduction in mortality, 4% reduction in hospitalization length, and 85% reduction in unnecessary atrial fibrillation alerts. Implicity serves over 100,000 patients across more than 250 medical facilities in the United States and Europe, with offices in Cambridge, Massachusetts, and Paris, France.

Menicon Co., Ltd. is Japan's first and largest contact lens manufacturer, founded in 1951 and represented in over 80 countries. The company specializes exclusively in contact lens-related business, encompassing material development, lens design, manufacturing, and care solutions. Menicon manufactures soft contact lenses, specialty lenses (including scleral lenses such as Time XL), myopia management products, and contact lens care solutions. The company serves patients of all ages, from children to elderly, with a focus on delivering safe contact lenses and prioritizing eye health. As the only manufacturer globally dedicated entirely to all areas of contact lens-related business, Menicon combines precision craftsmanship with innovation in vision correction. The company maintains regulatory approvals across multiple markets, including China, and operates through subsidiary companies in regions including Southeast Asia, Europe, Middle East, and Africa (EMEA).

Buoy Health is an AI-powered digital health platform that provides symptom assessment, clinical decision support, and care navigation for consumers. The platform combines machine learning algorithms with clinician-reviewed medical content to help users identify potential health conditions based on self-reported symptoms and receive personalized guidance on appropriate care pathways. Founded by physicians and data scientists at Harvard Innovation Labs, Buoy integrates artificial intelligence-driven triage with expert-curated health information, enabling users to make informed decisions about seeking professional medical care. The company serves individuals seeking accessible, evidence-based health guidance and care coordination outside traditional clinical settings.

REEV is a medical robotics company specializing in personalized mobility solutions for individuals with neurological gait disorders, including stroke survivors, multiple sclerosis, and paraplegia patients. The company offers an integrated two-product platform: REEV SENSE, an AI-powered wearable gait analysis system that captures real-time kinematic data via dual sensors, and DREEVEN, a motorized knee-ankle-foot orthosis (KAFO) that provides personalized robotic assistance based on patient-specific gait signatures. The system enables certified orthotists and rehabilitation clinics to perform rapid gait calibration, monitor patient progression through mobile analytics, and deliver customized motor control assistance in outpatient and clinical settings. REEV's technology integrates electro-hydraulic actuation with machine learning algorithms to adapt orthotic support dynamically to each patient's walking pattern, improving functional mobility and independence.

Epicore Biosystems is a digital health and biomedical wearables company specializing in sweat-sensing microfluidic technology. The company develops non-invasive biowearable devices that analyze sweat biomarkers—including electrolytes, metabolites, nutrients, and stress markers—to provide real-time physiological insights. Epicore's proprietary sweat microfluidic sensing platform integrates cloud analytics for personalized health monitoring and decision support. The company's primary solutions target three market segments: industrial safety (workplace hydration and heat stress monitoring), sports and fitness (performance optimization and recovery tracking), and clinical research (biomarker discovery and FDA-registered data collection systems). Epicore's Connected Hydration platform delivers continuous monitoring with real-time alerts, and its Discovery Patch provides laboratory-grade sweat analysis for research applications. The company has established partnerships with major enterprises including Chevron, PepsiCo, Gatorade, and the U.S. Air Force Research Laboratory, deploying solutions across energy, construction, and professional sports sectors.

RxCap is a Boston-based provider of connected remote monitoring solutions specializing in medication adherence and patient engagement. The platform combines cellular smart medication adherence devices (smart caps, pill organizers) with cloud-based monitoring software and APIs to deliver real-time adherence insights for healthcare providers, payers, and pharmaceutical manufacturers. RxCap serves pharmacies, health plans, PBMs, and life sciences organizations by enabling scalable remote monitoring programs that help close adherence gaps, personalize interventions, and improve outcomes for patients with chronic and complex health conditions. The company offers modular products including adherence monitoring devices, proprietary data hubs, patient activation portals and mobile apps, and an API library for integration with EHR systems like Epic.